Dysregulated synaptic gene expression in oligodendrocytes of spinal and bulbar muscular atrophy
Authors:
- Madoka IidaMIMadoka Iida
- Kentaro SahashiKSKentaro Sahashi
- Tomoki HirunagiTHTomoki Hirunagi
- Kenji SakakibaraKSKenji Sakakibara
- Kentaro MaedaKMKentaro Maeda
- Yohei IguchiYIYohei Iguchi
- Jiayi LiJLJiayi Li
- Yosuke OguraYOYosuke Ogura
- Masaki IizukaMIMasaki Iizuka
- Tomohiro AkashiTATomohiro Akashi
- Kunihiko HinoharaKHKunihiko Hinohara
- Shouta SugioSSShouta Sugio
Open Access
- 6 May 2025
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (12)
Abstract
Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disease caused by an expanded CAG repeat in the androgen receptor ( AR ) gene. To elucidate the cell type–specific temporal gene expression in SBMA, we performed single-nucleus RNA sequencing on the spinal cords of an SBMA mouse model (AR-97Q). Among all cell types, oligodendrocytes had the highest number of differentially expressed genes before disease onset. Analysis of oligodendrocyte clusters suggested that pathways associated with cation channels and synaptic function were activated before disease onset, with increased output from oligodendrocytes to neurons in AR-97Q mice compared with wild-type mice. These changes in the early stages were abrogated at the advanced stages. An oligodendrocyte model of SBMA showed phenotypes similar to those of AR-97Q mice at early stages, such as increased transcriptional changes in synapse organization, and Ca 2+ imaging of oligodendrocytes in AR-97Q mice revealed the increased Ca 2+ responses. A coculture system of primary rat oligodendrocytes and neurons revealed that the mutant AR in oligodendrocytes affected the activity and synchronization of neurons. These findings suggest that dysregulated cell-to-cell communication plays a critical role in early SBMA pathology and that synaptic or ion channel–related proteins, such as contactin associated protein 2 (Cntnap2) and NALCN channel auxiliary factor 1 (Fam155a), are potential therapeutic targets for SBMA.Keywords
All Related Versions
Funding Information
- Japan Society for the Promotion of Science (JP21K20686)
- Japan Society for the Promotion of Science (JP22K15705)
- Japan Society for the Promotion of Science (JP20H00527)
- Japan Society for the Promotion of Science (JP23H00420)
- Japan Society for the Promotion of Science (JP22nk0101575)
- Japan Society for the Promotion of Science (JP22K15706)
- Japan Agency for Medical Research and Development (JP23bm1423003)
- Japan Agency for Medical Research and Development (JP22am0401007)
- Takeda Science Foundation (a grant from Takeda Science Foundation)
- Japanese SBMA Patient Group (a grant from the Japanese SBMA Patient Group Research Support Program)
- Japan Society for the Promotion of Science (JP22H04923 (CoBiA))
This publication has 68 references indexed in Scilit:
- Exercise attenuates polyglutamine‐mediated neuromuscular degeneration in a mouse model of spinal and bulbar muscular atrophyJournal of Cachexia, Sarcopenia and Muscle, 2023
- hdWGCNA identifies co-expression networks in high-dimensional transcriptomics dataCell Reports Methods, 2023
- Loss of CNTNAP2 Alters Human Cortical Excitatory Neuron Differentiation and Neural Network DevelopmentBiological Psychiatry, 2023
- Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trialAnnals of Clinical and Translational Neurology, 2022
- Integrated analysis of multimodal single-cell dataCell, 2021
- Molecular Architecture of the Mouse Nervous SystemCell, 2018
- Impairments in Motor Neurons, Interneurons and Astrocytes Contribute to Hyperexcitability in ALS: Underlying Mechanisms and Paths to TherapyMolecular Neurobiology, 2017
- Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat dietActa Neuropathologica, 2016
- Intrinsic Membrane Hyperexcitability of Amyotrophic Lateral Sclerosis Patient-Derived Motor NeuronsCell Reports, 2014
- Oligodendrocytes: biology and pathologyActa Neuropathologica, 2009